BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song J, Lu C, Leszek J, Zhang J. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms. Int J Mol Sci 2021;22:10118. [PMID: 34576281 DOI: 10.3390/ijms221810118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Paramanick D, Singh VD, Singh VK. Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases. Journal of Controlled Release 2022;351:638-655. [DOI: 10.1016/j.jconrel.2022.09.058] [Reference Citation Analysis]
2 Zhang S, Gan L, Cao F, Wang H, Gong P, Ma C, Ren L, Lin Y, Lin X. The barrier and interface mechanisms of the brain barrier, and brain drug delivery. Brain Res Bull 2022;190:69-83. [PMID: 36162603 DOI: 10.1016/j.brainresbull.2022.09.017] [Reference Citation Analysis]
3 Méndez-garcía LA, Escobedo G, Minguer-uribe AG, Viurcos-sanabria R, Aguayo-guerrero JA, Carrillo-ruiz JD, Solleiro-villavicencio H. Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. Front Cell Neurosci 2022;16:977039. [DOI: 10.3389/fncel.2022.977039] [Reference Citation Analysis]
4 Reginald-Opara JN, Tang M, Svirskis D, Chamley L, Wu Z. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier. Int J Pharm 2022;:122152. [PMID: 36055442 DOI: 10.1016/j.ijpharm.2022.122152] [Reference Citation Analysis]
5 Simonis B, Vignone D, Gonzalez Paz O, Donati E, Falchetti ML, Bombelli C, Cellucci A, Auciello G, Fini I, Galantini L, Syeda RZ, Mazzonna M, Mongiardi MP, Buonocore F, Ceccacci F, Di Marco A, Mancini G. Transport of cationic liposomes in a human blood brain barrier model: Role of the stereochemistry of the gemini amphiphile on liposome biological features. J Colloid Interface Sci 2022;627:283-98. [PMID: 35853406 DOI: 10.1016/j.jcis.2022.07.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pandya T, Dharamsi A. Preparation and Optimization of Leuprolide Acetate Nanoparticles Using Response Surface Methodology: In Vitro and Ex Vivo Evaluation. ASSAY and Drug Development Technologies 2022;20:237-249. [DOI: 10.1089/adt.2022.051] [Reference Citation Analysis]
7 Poudel P, Park S. Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics 2022;14:835. [DOI: 10.3390/pharmaceutics14040835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
8 Persano F, Gigli G, Leporatti S. Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas. IJMS 2022;23:3360. [DOI: 10.3390/ijms23063360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Liu J, Guo Z, Yan X, Yang Y, Huang S. Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1. Front Aging Neurosci 2021;13:755392. [DOI: 10.3389/fnagi.2021.755392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]